These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 22178578)
21. Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs. Couture L; Richer LP; Mercier M; Hélie C; Lehoux D; Hossain SM J Pharmacol Toxicol Methods; 2013; 67(2):91-7. PubMed ID: 23231926 [TBL] [Abstract][Full Text] [Related]
23. Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells. Giri H; Panicker SR; Cai X; Biswas I; Weiler H; Rezaie AR Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836597 [TBL] [Abstract][Full Text] [Related]
24. The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Flick MJ; Chauhan AK; Frederick M; Talmage KE; Kombrinck KW; Miller W; Mullins ES; Palumbo JS; Zheng X; Esmon NL; Esmon CT; Thornton S; Becker A; Pelc LA; Di Cera E; Wagner DD; Degen JL Blood; 2011 Jun; 117(23):6326-37. PubMed ID: 21436072 [TBL] [Abstract][Full Text] [Related]
25. Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis. Heran C; Morgan S; Kasiewski C; Bostwick J; Bentley R; Klein S; Chu V; Brown K; Colussi D; Czekaj M; Perrone M; Leadley R Eur J Pharmacol; 2000 Feb; 389(2-3):201-7. PubMed ID: 10688985 [TBL] [Abstract][Full Text] [Related]
26. The anticoagulant thrombin mutant W215A/E217A has a collapsed primary specificity pocket. Pineda AO; Chen ZW; Caccia S; Cantwell AM; Savvides SN; Waksman G; Mathews FS; Di Cera E J Biol Chem; 2004 Sep; 279(38):39824-8. PubMed ID: 15252033 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor. Pakala R; Liang CT; Benedict CR Thromb Res; 2000 Oct; 100(1):89-96. PubMed ID: 11053621 [TBL] [Abstract][Full Text] [Related]
28. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. Rezaie AR; Cooper ST; Church FC; Esmon CT J Biol Chem; 1995 Oct; 270(43):25336-9. PubMed ID: 7592694 [TBL] [Abstract][Full Text] [Related]
29. Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke. Berny-Lang MA; Hurst S; Tucker EI; Pelc LA; Wang RK; Hurn PD; Di Cera E; McCarty OJ; Gruber A Stroke; 2011 Jun; 42(6):1736-41. PubMed ID: 21512172 [TBL] [Abstract][Full Text] [Related]
30. Calcium-binding sites of the thrombin-thrombomodulin-protein C complex: possible implications for the effect of platelet factor 4 on the activation of vitamin K-dependent coagulation factors. Yang L; Rezaie AR Thromb Haemost; 2007 Jun; 97(6):899-906. PubMed ID: 17549291 [TBL] [Abstract][Full Text] [Related]
31. The thrombin mutant W215A/E217A shows safe and potent anticoagulant and antithrombotic effects in vivo. Gruber A; Cantwell AM; Di Cera E; Hanson SR J Biol Chem; 2002 Aug; 277(31):27581-4. PubMed ID: 12070133 [TBL] [Abstract][Full Text] [Related]
33. Thrombin cleaves and activates the protease-activated receptor 2 dependent on thrombomodulin co-receptor availability. Heuberger DM; Franchini AG; Madon J; Schuepbach RA Thromb Res; 2019 May; 177():91-101. PubMed ID: 30861432 [TBL] [Abstract][Full Text] [Related]
34. Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. Golino P; Ragni M; Cirillo P; D'Andrea D; Scognamiglio A; Ravera A; Buono C; Ezban M; Corcione N; Vigorito F; Condorelli M; Chiariello M Circ Res; 1998 Jan 9-23; 82(1):39-46. PubMed ID: 9440703 [TBL] [Abstract][Full Text] [Related]
35. Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis. Ono M; Nawa K; Marumoto Y Thromb Haemost; 1994 Sep; 72(3):421-5. PubMed ID: 7855794 [TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin. Tawara S; Sakai T; Matsuzaki O Thromb Res; 2016 Nov; 147():72-79. PubMed ID: 27693845 [TBL] [Abstract][Full Text] [Related]
37. Rational design of a potent anticoagulant thrombin. Cantwell AM; Di Cera E J Biol Chem; 2000 Dec; 275(51):39827-30. PubMed ID: 11060281 [TBL] [Abstract][Full Text] [Related]
38. Thrombin interacts with thrombomodulin, protein C, and thrombin-activatable fibrinolysis inhibitor via specific and distinct domains. Hall SW; Nagashima M; Zhao L; Morser J; Leung LL J Biol Chem; 1999 Sep; 274(36):25510-6. PubMed ID: 10464282 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Thiagarajan P; Benedict CR Circulation; 1997 Oct; 96(7):2339-47. PubMed ID: 9337209 [TBL] [Abstract][Full Text] [Related]
40. The antithrombotic efficacy of AT-1459, a novel, direct thrombin inhibitor, in rat models of venous and arterial thrombosis. Cho JH; Yun CH; Seo HS; Koga T; Dan T; Koo BA; Kim HY Thromb Haemost; 2001 Dec; 86(6):1512-20. PubMed ID: 11776321 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]